Loading…
Simple
Expanded
Grid
By Venue
Monday, May 6
 

7:30am EDT

Registration & Networking Breakfast
Monday May 6, 2024 7:30am - 8:30am EDT
The Westin, Jersey City Newport III
  Networking

8:30am EDT

Chairperson’s Opening Remarks
Speakers
avatar for Stephanie Otis

Stephanie Otis

Vice President of US Medical Affairs, Ferring Pharmaceuticals
Stephanie Otis is the Vice President of US Medical Affairs at Ferring Pharmaceuticals.  In her role, she is responsible for driving strategies that contribute to medical excellence and scientific leadership, bringing life changing therapies to help people build families and live... Read More →

Monday May 6, 2024 8:30am - 8:45am EDT
Newport III
  General Session

8:45am EDT

Navigating Excellence: Chief Medical Officer Perspectives on Long-Term Medical Affairs Goals
  • Explore the critical role of Medical Affairs in bringing a holistic perspective to product development 
  • Highlight the value of medical affairs across a products life cycle 
  • Discuss long term views for innovation and investment 
Moderators
avatar for Gail Cawkwell, MD, Ph.D.

Gail Cawkwell, MD, Ph.D.

Former Chief Medical Officer, Aclaris Therapeutics
Gail Cawkwell, MD, PhD has served as Aclaris’ Chief Medical Officer since June 2022. Dr. Cawkwell, a pediatric rheumatologist and epidemiologist, has over 23 years of pharmaceutical clinical development and medical affairs experience, including fifteen years as an enterprise and... Read More →

Speakers
avatar for Reshma Rangwala, MD, Ph.D.

Reshma Rangwala, MD, Ph.D.

Chief Medical Officer, Karyopharm Therapeutics
Dr. Rangwala brings more than a decade of experience in oncology and drug development to her role at Karyopharm. She was most recently the Chief Medical Officer at Aravive, where she led the clinical development of batiraxcept across multiple tumor types. Prior to Aravive, she served... Read More →
avatar for Kirk Shepard, M.D.

Kirk Shepard, M.D.

Chief Medical Officer, PDS Biotechnology
Kirk Shepard, M.D., is a U.S. board-certified medical oncologist and hematologist with more than 30 years of experience in the pharmaceutical industry. Prior to PDS Biotechnology, he was Chief Medical Officer, Senior Vice President and Head of Global Medical Affairs Oncology at Eisai... Read More →
avatar for Stuart Hart, M.D.

Stuart Hart, M.D.

Chief Medical Officer, Integra LifeSciences
Dr. Stuart Hart is the corporate vice president and chief medical officer. He is responsible for Integra’s worldwide clinical development activities, including clinical research, clinical trial operations and medical affairs. Dr. Hart is also responsible for scientific and medical... Read More →

Monday May 6, 2024 8:45am - 9:30am EDT
Newport III
  General Session

9:30am EDT

Reimagining Medical Content Development for the Era of High-Speed, Snackable Scientific Exchange
  • Discuss the challenges faced by medical affairs organizations in creating adaptable content that meets the diverse needs of stakeholders, therapeutic areas, channels, internal functions, and regions
  • Examine the limitations of traditional workflows in medical content development, such as delays and redundant efforts stemming from linear processes and the importance of adopting agile methodologies to streamline content creation, enable faster adaptation, and more effective medical engagement
  • Hear a vision for how the content development process can be re-imagined to guide efficient design, development and distribution of compelling modular content, at speed and at scale 
Speakers
avatar for Tim Mitchell, Ph.D.

Tim Mitchell, Ph.D.

Managing Director, Medical Communications & Innovation, Klick
Tim architected Klick's Transformative Medical Agency Partner model, pushing beyond traditional boundaries with a blend of high-speed, high-science, and high-tech solutions to enable a modernized approach to achieving medical-engagement excellence and impact. Leveraging Klick's technology... Read More →
avatar for Rachael Harrison, Ph.D.

Rachael Harrison, Ph.D.

Vice President of Science and Regulatory, Klick
As a Vice President of Science and Regulatory at Klick, Rachael manages many departments of Medical and Regulatory Editors (composed of scientists, former HCPs and regulatory professionals) and several client portfolios. She also serves as a regulatory and medical/scientific consultant... Read More →

Monday May 6, 2024 9:30am - 10:00am EDT
Newport III
  General Session

10:00am EDT

The Future of Omnichannel Communication: Breaking Barriers and Enhancing Customer Engagement
  • Explore challenges hindering the adoption of true omnichannel communication 
  • Understand the importance of data analytics in shaping customer engagement models and strategies to analyze customer data more effectively 
  • Identify methods to streamline content development for diverse channels and ensure it is adaptable and effective across various platforms 
  • Examine how to develop a strategic plan for enhancing customer journey experiences 
Moderators
avatar for Heather Abourjaily

Heather Abourjaily

Head of Global Scientific Communications, Rocket Pharmaceuticals
Dr. Abourjaily is an experienced Scientific Communications leader with over 20 years of progressively increasing responsibilities in the biopharmaceutical industry.  Her global scientific communication roles have encompassed Strategic Scientific Communications, Publications, Medical... Read More →

Speakers
avatar for Divyesh (Div) Khetia

Divyesh (Div) Khetia

Vice President, Head of Medical Affairs Channel Excellence, Pfizer
avatar for Donnie Wooten Jr. Pharm.D.

Donnie Wooten Jr. Pharm.D.

Global Head Strategic Medical Content & Omnichannel, Organon
avatar for Stephanie Otis

Stephanie Otis

Vice President of US Medical Affairs, Ferring Pharmaceuticals
Stephanie Otis is the Vice President of US Medical Affairs at Ferring Pharmaceuticals.  In her role, she is responsible for driving strategies that contribute to medical excellence and scientific leadership, bringing life changing therapies to help people build families and live... Read More →

Monday May 6, 2024 10:00am - 10:45am EDT
Newport III
  General Session
  • QTag featuredsession

10:45am EDT

Networking Break
Monday May 6, 2024 10:45am - 11:15am EDT
The Westin, Jersey City Newport III
  Networking

11:15am EDT

Collaboration for Success: Expanding Stakeholder Engagement in Medical Affairs & Bridging the Medical-Commercial Divide
  • Gain insights into the dynamics of successful collaboration between medical and commercial teams, including practical tips for fostering a productive and mutually beneficial relationship 
  • Understand the importance of defining success metrics and measuring the impact of collaborative efforts, enabling teams to track progress and optimize strategies for improved outcomes 
  • Learn how to cultivate a culture of innovation and collaboration within highly regulated environments, and discover strategies for leading by example to inspire teams to embrace collaborative practices in medical affairs 
Moderators
avatar for Isabel Firmino, M.D.

Isabel Firmino, M.D.

Senior Vice President, Head Medical Affairs, Insmed Incorporated
Well-respected medical leader and Board-certified Pharmaceutical Physician with over 25-years of experience, who is passionate for transforming outcomes of those living with a rare disease and has a track record of contributing to corporate goals through strategically partnering with... Read More →

Speakers
avatar for Carolyn Reever, PhD

Carolyn Reever, PhD

Global Head, Neuropsychiatry Medical Affairs, Biogen
Dr Carolyn Reever is an accomplished strategic & agile leader who builds & transforms teams, functions & frameworks to deliver results. As a PhD in Neuropharmacology, she is a demonstrated subject matter expert in Neuroscience & Rare Disease, with additional Therapeutic and Disease... Read More →
avatar for Dr. Osama Hashmi, MD

Dr. Osama Hashmi, MD

Co-Founder, Impiricus
Osama Hashmi MD MPH is a practicing dermatologist and the Chief Medical Officer and a cofounder of Impiricus. He has been involved in healthcare technology and policy for over ten years - selling a health tech company during college, starting one of the first teledermatology platforms... Read More →
avatar for Björn Oddens

Björn Oddens

Senior Vice-President and Head, Global Medical & Scientific Affairs, Merck
Björn Oddens is senior vice president and head of Global Medical & Scientific Affairs at Merck Research Laboratories. Björn has led the global Medical Affairs teams for over two decades. Prior to his current role, he led Merck’s medical affairs organization in Europe, Middle East... Read More →
avatar for Temi Folaranmi

Temi Folaranmi

Vice President and Therapeutic Area Lead for Vaccines Medical and Clinical Affairs, GSK
Dr. Temi Folaranmi is Vice President and Therapeutic Area Lead for Vaccines Medical and Clinical Affairs at GSK in the United States. In his current role, he provides strategic leadership to a team of physicians, pharmacists, epidemiologists, and health outcome scientists engaging... Read More →

Monday May 6, 2024 11:15am - 12:00pm EDT
Newport III
  General Session
  • QTag featuredsession

12:00pm EDT

Measuring Medical Impact: The Journey From Lofty Concept to Real World Execution
  • Hear reflections on lessons learned- extracting value from experience 
  • Discuss a practical guidance for organizational readiness 
  • Explore best practices for measuring impact 
Speakers
avatar for Christine Medeiros

Christine Medeiros

Sr. Director, Strategic Insights, H1
Chris is Sr. Director of Strategic Insights at H1 and leads a team of dedicated data analysts with SME in the life sciences, who drive maximum value for clients by helping them solve business challenges with data. Her team derives novel insights from H1’s vast data assets through... Read More →

Monday May 6, 2024 12:00pm - 12:30pm EDT
Newport III
  General Session

12:30pm EDT

Networking Lunch
Monday May 6, 2024 12:30pm - 1:30pm EDT
The Westin, Jersey City Newport III
  Networking

1:30pm EDT

Revolutionizing Launch Success: Redefining Metrics and Strategies
  • Explore why traditional launch success metrics may no longer suffice and discover new, more dynamic approaches to measuring and achieving launch success 
  • Highlight the critical role of medical affairs in shaping product labels, indications, and overall launch strategy from the early stages 
  • Delve into the need for early collaboration to integrate evidence generation, patient considerations, and market readiness into launch planning 
  • Understand the critical steps and considerations for initiating MSLs in the launch plan and aligning launch strategies with therapeutic goals, market dynamics, and available data. 
Moderators
avatar for Gregory Rippon, MD, MS, FAAN

Gregory Rippon, MD, MS, FAAN

Vice President & Chief Medical Partner, Neurology, Ophthalmology, & Internal Medicine, Genentech
Gregory A. Rippon, MD, MS, FAAN is Vice President and Chief Medical Partner, Neurology, Ophthalmology and Internal Medicine at Genentech. In his role, Dr. Rippon leads U.S. medical affairs portfolio and pipeline medical programs across these therapeutic areas and is a member of the... Read More →

Speakers
avatar for Suzanne Giordano, Ph.D.

Suzanne Giordano, Ph.D.

Associate Vice President, Head of Field Medical, Axsome Therapeutics
avatar for Robyn Bilmes, PharmD, BCOP.

Robyn Bilmes, PharmD, BCOP.

Senior Vice President, Global Head of Medical Affairs, Genmab
Robyn is the Senior VP, Global Head of Medical Affairs at Genmab.  Robyn joined Genmab in July 2021 as Vice President, Head of US Medical Affairs where she was responsible for building an integrated Medical Affairs organization for the US and providing strategic leadership... Read More →
avatar for Brieana Cox Buckley, PharmD, MS

Brieana Cox Buckley, PharmD, MS

Vice President, Medical Affairs and Patient Advocacy, Editas Medicine
Dr. Brieana Buckley joined Editas Medicine in May 2023 as Vice President, Medical Affairs and Patient Advocacy. She completed her PharmD from University of Utah followed by a Managed Care Residency at SelectHealth and a subsequent master’s degree in Pharmacoeconomics from the University... Read More →

Monday May 6, 2024 1:30pm - 2:15pm EDT
Newport III
  General Session
  • QTag featuredsession

2:15pm EDT

How AI/ML Can Impact Medical Affairs
  • Understand the differences and role of Artificial Intelligence and Machine Learning within Medical Affairs
  • Discuss case studies for how we are using advanced analytics in day-to-day Medical Affairs work.
  • Review how we are using AI and ML to customize field medical interactions.
Speakers
avatar for Nathan Lear

Nathan Lear

Head, Advanced Analytics and Clinical Trial Efficiency, AstraZeneca
Nathan Lear: Pioneering Advanced Analytics in Oncology Medical AffairsNathan stands at the forefront of revolutionizing the landscape of medical affairs through his visionary leadership and expertise in advanced analytics and clinical trial efficiency. As the Head of Advanced Analytics... Read More →

Monday May 6, 2024 2:15pm - 2:45pm EDT
Newport III
  General Session

2:45pm EDT

Measuring and Conveying the Value of Medical Affairs
  • Recap the challenge of measuring impact in Medical Affairs
  • Cover different frameworks and types of metrics that may be useful in understanding the value of medical affairs efforts
  • Discuss how to approach (e.g., design, scale, and communicate) impact assessments using best practices from implementation science
Speakers
avatar for Dr. Diana Morgenstern

Dr. Diana Morgenstern

Executive Strategist, Medical Affairs, IQVIA
Diana Morgenstern, MD, FACP is Executive Strategist in the IQVIA US Medical Affairs Center of Excellence. A general internist whose varied career to date includes depth and breadth in clinical practice, medical education, medical communications, and the pharmaceutical industry, she... Read More →
avatar for Javier Lopez-Molina

Javier Lopez-Molina

Senior Director, Medical Strategy, Medical Affairs, IQVIA
Javier Lopez-Molina has over 10 years of experience in medical affairs, commercial, clinical, and corporate strategy. At IQVIA, he leads the US medical affairs strategy business segment, driving innovative medical affairs strategy portfolio of offerings. This includes guiding the... Read More →

Monday May 6, 2024 2:45pm - 3:15pm EDT
Newport III
  General Session

3:15pm EDT

Networking Break
Monday May 6, 2024 3:15pm - 3:45pm EDT
The Westin, Jersey City Newport III
  Networking

3:45pm EDT

From Burden to Benefit: Transforming Publication Management Is Easier Than You Think
  • Discuss the common frustrations and hindrances faced by medical affairs leaders in managing publications due to cumbersome software systems
  • Highlight the potential gains and benefits of automating publications management, emphasizing the opportunity for increased productivity and resource optimization
  • Explore how process automation can transform the publications management process, making it more efficient, scalable, and adaptable to the needs of both emerging and established companies
Speakers
avatar for Wallace Holland

Wallace Holland

Chief Operating Officer, BP Logix
Wallace has helped multiple medical affairs leaders at life sciences companies automate their publications management processes, reducing the administrative burden, increasing publication time, and reducing costs.
avatar for Peter Herout

Peter Herout

Associate Director of Scientific Communications, Esperion Therapeutics
Peter joined Esperion as Associate Director of Scientific Communications 20 years in clinical pharmacy. He is responsible for a range of critical publication tasks — from identifying topics and authors, to managing submissions and reviews.

Monday May 6, 2024 3:45pm - 4:15pm EDT
Newport III

4:15pm EDT

Quantifying Impact: Unveiling Metrics That Resonate with Stakeholders

  • Discuss the importance of identifying and tailoring metrics to the specific needs and perspectives of various stakeholders within the healthcare ecosystem - both internally, including executive management and cross-functional partners, as well as externally, including providers, payors, and patients.
  • Highlight the significance of clinically relevant metrics to quantify the impact of Medical Affairs strategic and tactical activities, e.g., educational, and one-on-one field engagement activities that potentially reflect improvement by the medical community's understanding of treatment options and the diagnosis of the therapeutic area.
  • Explore potential real-world data sources, e.g., electronic health records, claims data, and patient-reported outcomes, in quantifying the impact of Medical Affairs activities. Discuss analytics for effectively capturing, analyzing, and interpreting real-world evidence to potentially explain the meaning of insights and to drive better decision-making around Medical Affairs resource allocation.
Speakers
avatar for Daniel Snyder, Ph.D.

Daniel Snyder, Ph.D.

Senior Vice President, Medical Affairs, BioPharma & Women’s Health, Sumitomo Pharma America, Inc.

Monday May 6, 2024 4:15pm - 4:45pm EDT
Newport III
  General Session

4:45pm EDT

Revolutionizing HCP Engagement: How Data Analytics and GenAI are Shaping the Future of Medical Affairs
  • Discuss the increasing expectation for personalized communication in the digital age, where HCPs expect content that is not only relevant to their practice but also delivered in a manner and time that suits their preferences.
  • Examine the potential of genAI tools in revolutionizing the way scientific information is presented to HCPs. Examples could include AI-generated visuals that explain complex mechanisms of action, or AI-driven platforms that curate and personalize scientific content for different HCP personas.
  • Highlight the importance of not just what is communicated, but how and when it's delivered. Showcase how data analytics can identify the most effective channels and optimal times for engaging specific HCP personas, whether through social media, email marketing, webinars, or even virtual reality platforms.
  • Emphasize that the end goal of leveraging data analytics and genAI is not just about streamlining processes or boosting engagement metrics but about fundamentally improving health outcomes.

Speakers
avatar for Michelle Dunst

Michelle Dunst

Managing Director, Real Chemistry
Michelle Dunst is a leader at the intersection of analytics, insights, and healthcare communications, serving as Managing Director of Analytics and Insights at Real Chemistry. Her robust background, spanning over a decade, has seen her leverage insights and analytics to drive strategic... Read More →
avatar for Ujwal Pyati, PhD

Ujwal Pyati, PhD

President, Scientific and Medical Affairs, Real Chemistry
Since completing his postdoctoral fellowship and joining the healthcare industry in 2011, Dr. Ujwal Pyati has been an integral force in driving the success of a wide range of high-science brands. With his expertise in cell signaling pathways and targeted therapies, Dr. Pyati has a... Read More →

Monday May 6, 2024 4:45pm - 5:15pm EDT
Newport III
  General Session

5:15pm EDT

Fireside Chat- Demonstrating Value: Creating a Medical Affairs Organization That's Fit For The Future
  • Highlight the importance of understanding and meeting the evolving needs of key stakeholders with patients at the center 
  • Examine how emerging technologies, such as artificial intelligence and real-world evidence, can be harnessed to elevate the impact and efficiency of Medical Affairs activities and drive value-based care to improve patient outcomes 
  • Discuss the essential components of an agile Medical Affairs organization and how the function has transformed over the years; hear insights into fostering a culture of continuous learning and adaptability among team members and how to effectively communicate and engage with healthcare providers today 
  • Address the challenges of measuring the impact of Medical Affairs initiatives and identify metrics and key performance indicators that effectively demonstrate the value delivered by the Medical Affairs function 
 
Speakers
avatar for Vera Mastey

Vera Mastey

Vice President, Health Economics and Outcomes Research, Regeneron
Vera joined Regeneron in 2013 when she accepted the unique opportunity to build an HEOR team from the ground up for a company she had admired from afar for many years. In this role, Vera has been fortunate to recruit and lead a team whose mission it is to deliver strategic insights... Read More →
avatar for Johnathan Lancaster, MD, PhD

Johnathan Lancaster, MD, PhD

Senior Vice President and Head of Global Medical Affairs, Regeneron
Johnathan M. Lancaster, MD, PhD, joined Regeneron in 2019 as a Vice President and now serves as Senior Vice President and Head of Global Medical Affairs. Prior to joining Regeneron, Dr. Lancaster served as Chief Medical Officer at Myriad Genetics, Inc., following more than a decade... Read More →

Monday May 6, 2024 5:15pm - 5:45pm EDT
Newport III
  General Session
  • QTag featuredsession

5:45pm EDT

Chairperson’s Closing Remarks
Speakers
avatar for Stephanie Otis

Stephanie Otis

Vice President of US Medical Affairs, Ferring Pharmaceuticals
Stephanie Otis is the Vice President of US Medical Affairs at Ferring Pharmaceuticals.  In her role, she is responsible for driving strategies that contribute to medical excellence and scientific leadership, bringing life changing therapies to help people build families and live... Read More →

Monday May 6, 2024 5:45pm - 6:00pm EDT
Newport III
  General Session

6:00pm EDT

Cocktail Reception
Monday May 6, 2024 6:00pm - 7:00pm EDT
The Westin, Jersey City Newport III
  Networking
 
Tuesday, May 7
 

8:00am EDT

Registration and Networking Breakfast
Tuesday May 7, 2024 8:00am - 9:00am EDT
  Networking

9:00am EDT

Chairperson’s Opening Remarks
Speakers
avatar for Kanchan Relwani

Kanchan Relwani

Senior Vice President, Head of Medical Affairs, Alkermes
Kanchan Relwani, M.D. serves as Alkermes’ Senior Vice President of Medical Affairs. In this role, Dr. Relwani leads the Medical Affairs organization, including oversight of the Medical Strategy, Medical Operations & Alliances, Heath Economics and Outcomes Research, Medical Information... Read More →

Tuesday May 7, 2024 9:00am - 9:15am EDT
Newport III
  Track: Medical Affairs Strategy

9:00am EDT

Track Chairperson's Opening Remarks
Speakers
avatar for Melanie Fleeman, Ph.D.

Melanie Fleeman, Ph.D.

Executive Director, Head of Scientific Communications, Education & Digital Content, Bayer
Melanie Fleeman, PhD, serves as Executive Director and Head of Scientific Communications, Education & Digital Content, within the Oncology Global Medical Affairs group at Bayer. Melanie oversees a team of talented scientific experts in their mission to transform data into innovative... Read More →

Tuesday May 7, 2024 9:00am - 9:15am EDT
Newport I
  Track: Medical Communications

9:00am EDT

Track Chairperson’s Opening Remarks
Speakers
avatar for Jill Fenwick, Ph.D.

Jill Fenwick, Ph.D.

Global Head of Medical Learning, EMD Serono
Jill has a PhD in Lung Cancer plus 25 years in pharmaceutical industry in UK, initially in commercial, but then over 15 years in Medical Affairs. Predominantly in psychiatry and oncology therapy areas. As field-based Medical Affairs worked as an MSL, European MSL (responsible for... Read More →

Tuesday May 7, 2024 9:00am - 9:15am EDT
Newport II
  Track: MSL Best Practices

9:15am EDT

Keynote: Synergizing Strategies: Uniting Medical Affairs Through Language and Vision
  • Recognize the significance of establishing a common language and understanding of strategy across the medical affairs organization to ensure alignment and cohesion in achieving shared goals
  • Understand the pivotal role of communication in driving success, both internally and externally, and the impact it has on fostering collaboration, innovation, and stakeholder engagement
  • Embrace the power of diverse perspectives and effective communication in driving innovation and success within medical affairs, and recognize the importance of leadership in fostering a culture of openness and collaboration
Speakers
avatar for Debbie Bensen-Kennedy

Debbie Bensen-Kennedy

Vice President, North America Medical Affairs, CSL Behring
Debbie Bensen-Kennedy, MD is the Vice President, North America Medical Affairs. Debbie is responsible for providing strategic and operational medical leadership for the US and Canada and is a key member of the North America Commercial Operations leadership team. She has provided medical... Read More →

Tuesday May 7, 2024 9:15am - 9:45am EDT
Newport III
  Track: Medical Affairs Strategy

9:15am EDT

Keynote: Mapping the Medical Communication Landscape: Strategies for Seamless Collaboration from Pipeline to Launch
  • Discuss the importance of aligning medical communication strategies with product lifecycle stages, from early pipeline development to late-stage launch planning  
  • Highlight the pivotal role of scientific communication in shaping perceptions and influencing decision-making within the medical community 
  • Explore the nuances of global medical communication strategies and the critical role of cross-functional collaboration in driving market success 



Speakers
avatar for Poushali Mukherjea

Poushali Mukherjea

Vice President Medical Affairs Pipeline, Alnylam Pharmaceuticals
Experience in US and global medical leadership, launch planning, thought leader engagement, life cycle management, payer and access strategy support, medical communications, publication plans, and advisory boards. Extensive experience working in complex matrix organizations with... Read More →

Tuesday May 7, 2024 9:15am - 9:45am EDT
Newport I
  Track: Medical Communications

9:15am EDT

Keynote: Recognizing Your Impact in Field Medical: Learnings from Big Pharma and a Start-Up Environment
  • Discuss how each MSL can apply their experience and expertise to have a fulfilling career
  • Hear how MSLs can provide value to the healthcare communities they serve and the company they work for
  • Learn how MSLs can compliantly help the commercial team achieve their goals
Speakers
avatar for Mike Sopko

Mike Sopko

National Director of Field Medical, Zambon
Mike Sopko is the National Director of Field Medical at Zambon, a family-owned pharmaceutical company. Mike received his Doctor of Pharmacy from Rutgers University and completed a post-doctoral residency in neuropsychiatric pharmacy. Mike gained experience in both academic and clinical... Read More →

Tuesday May 7, 2024 9:15am - 9:45am EDT
Newport II
  Track: MSL Best Practices

9:45am EDT

Charting the Future: The Intersection of Technology and the Evolving Landscape in Medical Affairs
  • Highlight the opportunities and challenges in adopting technologies such as artificial intelligence, natural language processing, and other advanced tools within medical affairs  
  • Discuss the evolving role of social media: compliance, engagement, and best practices for capturing real world patient insights- Understand the current regulations surrounding social media and other digital platforms   
  • Explore the impact on traditional activities such as creating presentations, generating insights, and handling medical information in the era of automation and advanced technology  
  • Investigate the role of technology in collecting and processing data, particularly through natural language processing  
  • Hear how the acceleration of insights might influence the definition and implementation of strategies not only within medical affairs but across the broader organization

Moderators
avatar for Irene von Hennigs, PharmD.

Irene von Hennigs, PharmD.

Vice President Medical Affairs, Rare Disease, Amgen
Dr. von Hennigs is an accomplished leader in the biopharmaceutical industry with deep experience in building teams and ensuring sound medical strategy. She possesses scientific curiosity coupled with a business perspective that enables influence and leads transformational change... Read More →

Speakers
avatar for Michael Vinegra

Michael Vinegra

Senior Director, Medical Planning and Insights, Pfizer
avatar for Luca Dezzani

Luca Dezzani

Vice President US Oncology Medical Affairs, Johnson & Johnson
Luca Dezzani is a physician with extensive healthcare experience in clinical practice and in the pharmaceutical industry. He practiced as a physician in hematology-oncology and internal medicine before joining Novartis Oncology where he served in roles at national, regional, and global... Read More →
avatar for Sanjeev Welling

Sanjeev Welling

Co-Founder and CEO, Avira Digital
Sanjeev Welling, Co-Founder and CEO of Avira Digital, leads a bootstrapped pure-play digital transformation company with a proven track record. Avira Digital began the digitization of Medical Affairs journey in 2019-2020 and has since successfully launched two products - Evidence... Read More →
avatar for Herson Quiñones

Herson Quiñones

Vice President, US Medical Affairs, Specialty Therapy Area Head, GSK
Herson Quiñones is Vice President, US Medical Affairs, Specialty Therapy Area Head at GSK. He was previously the franchise head, US Medical Affairs in the immuno-inflammation team. Herson has worked at GSK since 2019.

Tuesday May 7, 2024 9:45am - 10:30am EDT
Newport III
  Track: Medical Affairs Strategy

9:45am EDT

Harnessing Data: A Prescription for Effective Medical Communications
  • Introduce the use data in medical communications by defining data types used to drive strategy 
  • Discuss approaches and best practices for targeted, consistent collection of stakeholder insights and streamlined analysis 
  • Explore the role of real-world evidence in shaping medical communications including challenges and opportunities when integrating RWE into communication strategies 
  • Examine how data might be leveraged to personalize medical communications for different audiences 
  • Review methods to establish KPI’s for evaluating the success of data-driven communication efforts 

Moderators
avatar for Christina Nixon, Ph.D.

Christina Nixon, Ph.D.

Senior Director, Medical and Scientific Communications, Alphanumeric

Speakers
avatar for Renu Juneja, Ph.D.

Renu Juneja, Ph.D.

Head, Scientific Evidence & Communications, Oncology US Medical Affairs, Johnson & Johnson
avatar for Teri Michelini, PharmD

Teri Michelini, PharmD

Head, Global Scientific Communications- Oncology, Sanofi
Teri is the currently Head of Global Scientific Communications for Oncology at Sanofi. Teri joined Sanofi in June 2017 with more than 30 years of oncology experience and 20+ year history within the Pharmaceutical and Biotechnology Industry with experience in a variety of roles in... Read More →
avatar for Heather Abourjaily

Heather Abourjaily

Head of Global Scientific Communications, Rocket Pharmaceuticals
Dr. Abourjaily is an experienced Scientific Communications leader with over 20 years of progressively increasing responsibilities in the biopharmaceutical industry.  Her global scientific communication roles have encompassed Strategic Scientific Communications, Publications, Medical... Read More →

Tuesday May 7, 2024 9:45am - 10:30am EDT
Newport I
  Track: Medical Communications

9:45am EDT

Strategic Field Medical Engagement: Building a Robust Plan for Successful Launch in Medical Affairs
  • Identify the optimal timing for initiating (MSLs) in the launch plan and address common challenges and pitfalls in the initial stages of MSL integration 
  • Discuss strategies for effective engagement and relationship-building with key stakeholders 
  • Explore how to leverage data-driven insights and experience to optimize launch support strategies

Moderators
avatar for Craig Klinger, R.Ph.

Craig Klinger, R.Ph.

Former Director - Global MSL Trainer, The Office of Medical Professional Development, Eli Lilly and Company
In Craig’s more than 30 years working at Eli Lilly and Company, he has successfully worked in various positions in multiple therapeutic areas including neuroscience, diabetes and osteoporosis. Craig was a founding member of the Medical Science Liaison (MSL) program at Lilly where... Read More →

Speakers
avatar for Mike Durkin

Mike Durkin

Regional Director, Medical Science Liaisons, Blueprint Medicines
Mike Durkin is a regional director of medical science liaisons for Blueprint Medicines since 2019 and has helped lead medical launches for two precision therapies across five indications in rare malignancies. He has helped expand and build field medical teams at Blueprint Medicines... Read More →
avatar for Carolyn Reever, PhD

Carolyn Reever, PhD

Global Head, Neuropsychiatry Medical Affairs, Biogen
Dr Carolyn Reever is an accomplished strategic & agile leader who builds & transforms teams, functions & frameworks to deliver results. As a PhD in Neuropharmacology, she is a demonstrated subject matter expert in Neuroscience & Rare Disease, with additional Therapeutic and Disease... Read More →
avatar for Suzanne Giordano, Ph.D.

Suzanne Giordano, Ph.D.

Associate Vice President, Head of Field Medical, Axsome Therapeutics

Tuesday May 7, 2024 9:45am - 10:30am EDT
Newport II
  Track: MSL Best Practices

10:30am EDT

Networking Break
Tuesday May 7, 2024 10:30am - 11:00am EDT
  Networking

11:00am EDT

Building Out Your Medical Affairs Team: How Early is Too Early?
  • Discuss advantages of integrating Medical Affairs functions at an earlier stage in the development timeline of assets, exploring the impact on the overall success of the company
  • Delve into the need for early collaboration to integrate evidence generation, patient considerations, and market readiness into launch planning
  • Advocate for a shift in mindset within R&D, emphasizing the importance of considering commercialization aspects throughout the clinical trial process
  • Identify effective coordination between R&D and medical affairs is essential for integrating evidence generation and patient considerations into launch planning, creating a seamless transition from clinical trials to commercialization
  • Explore how Medical Affairs functions in emerging biotech companies can adapt to and leverage evolving trends in precision medicine, real-world evidence, and patient-centric approaches
Moderators
avatar for Kanchan Relwani

Kanchan Relwani

Senior Vice President, Head of Medical Affairs, Alkermes
Kanchan Relwani, M.D. serves as Alkermes’ Senior Vice President of Medical Affairs. In this role, Dr. Relwani leads the Medical Affairs organization, including oversight of the Medical Strategy, Medical Operations & Alliances, Heath Economics and Outcomes Research, Medical Information... Read More →

Speakers
avatar for Tonia Nesheiwat, PharmD

Tonia Nesheiwat, PharmD

Vice President of Medical Affairs and Project Leadership, Caribou Biosciences
Tonia is the vice president of medical affairs and project leadership at Caribou Biosciences, responsible for developing and executing medical affairs strategy and supporting new product development. She brings 15 years of clinical development, submission and medical affairs experience... Read More →
avatar for Asya Kogan

Asya Kogan

Executive Director, Field Medical Oncology, Eisai
Asya Kogan, Pharm.D., serves as Executive Director, Field Medical, Global & US Oncology Medical Affairs at Eisai Inc. In this role, Dr. Kogan leads the Field Medical Affairs function in Oncology, including managing the Regional Directors of MSLs, Field Medical Directors and Field... Read More →
avatar for Sunil Mehta

Sunil Mehta

Vice President, Head of US Medical Affairs, Argenx
Sunil completed his PharmD from Rutgers University followed by a Medical Affairs and Medical Strategy post-doctoral fellowship at BMS in Cardiology & Infectious Diseases (ID) where he was involved in helping develop Medical strategy & Training for Medical Affairs and Commercial organizations... Read More →
avatar for Lorena Griparic, Ph.D.

Lorena Griparic, Ph.D.

Director, Medical Affairs and Safety, MannKind Corporation
Lorena is an experienced Medical Affairs professional, bringing to the discussion table > 15 years of biotech/pharmaceutical/device industry experience in various therapeutic areas, including diabetes, bone health, nephology, rare disease, ophthalmology. She is currently the Director... Read More →

Tuesday May 7, 2024 11:00am - 11:45am EDT
Newport III
  Track: Medical Affairs Strategy

11:00am EDT

Plain Language and Patient-Centric Communication: The Importance of the Patient Voice
  • Explore the importance of plain language in patient communication and beyond and recognize its role in reducing cognitive burden for all stakeholders, including patients and healthcare providers 
  • Delve into the significance of developing patient-centric communications and its crucial role in amplifying the patient voice, fostering trust, and driving innovation in medical affairs 
  • Examine the ways in which medical affairs can effectively engage with patients and advocacy groups 
Moderators
avatar for Alia Bucciarelli

Alia Bucciarelli

Senior Director, Medical Operations, Vertex Pharmaceuticals
Alia is a health communications leader with more than 20 years of experience in the field. In her career she and the teams she has led have developed innovative communication materials to lower cognitive burden and improve the usability of scientific information for health care providers... Read More →

Speakers
avatar for Brian Scheckner, PharmD

Brian Scheckner, PharmD

Senior Director, Medical Communications, Neuroscience Franchise Global Medical Affairs, Jazz Pharmaceuticals
Brian Scheckner, PharmD has worked in the pharmaceutical industry since 1999, serving primarily in publication and medical communication leadership roles. Brian is currently Senior Director, Medical Communications, at Jazz Pharmaceuticals, as the Jazz neuroscience medical communications... Read More →
avatar for Dakota Fisher-Vance

Dakota Fisher-Vance

Associate Director, Global Patient Advocacy, BioCryst Pharmaceuticals
Dakota Fisher-Vance received her B.A. in biology from Bryn Mawr College in May 2011 and a Familial Adenomatous Polyposis (F.A.P.) diagnosis two months later.Reluctantly, she traded in her post-college job for surgical gowns to have her cancerous colon removed. While working abroad... Read More →
avatar for Lori Neri, ANP, CMPP

Lori Neri, ANP, CMPP

Director of Scientific Communication, Global Medical Affairs, Insmed Incorporated
Lori Neri is a scientific communication professional with over 10 years of medical affairs experience. Her current position is as Director of Scientific Communications at Insmed Pharmaceuticals Incorporated. Lori has vast experience in rare diseases and small biotech. Past opportunities... Read More →
avatar for Sashi Nadanaciva, DPhil

Sashi Nadanaciva, DPhil

Director, Global Medical Affairs Oncology, Publications, Daiichi Sankyo
Sashi Nadanaciva has been a Publications Lead within Global Medical Affairs Oncology at Daiichi Sankyo since 2022. Before this, she was at Pfizer in a Global Scientific Communications role within oncology. She has more than 15 years of experience in the pharmaceutical industry, with... Read More →

Tuesday May 7, 2024 11:00am - 11:45am EDT
Newport I
  Track: Medical Communications

11:00am EDT

Empowering Your Field Medical Team: Strategies for Optimizing in the Omnichannel Era
  • Establish a clear and consistent definition of omnichannel in the context of medical affairs and address variations in how omnichannel is perceived and implemented across the industry 
  • Emphasize the importance of pre-execution planning, including profiling HCPs and understanding their preferences and balancing the needs of HCPs, patient populations, and medical objectives for effective omnichannel execution 
  • Explore the role of IT infrastructure in collecting and providing information about HCPs and the need for tools, training, and support for field medical teams to interpret and apply the collected data in their interactions 
  • Discuss the importance of strategic alignment to achieve coordination and consistency across field roles by aligning commercial and medical objectives to ensure a seamless omnichannel approach 

Moderators
avatar for Chad Schroer

Chad Schroer

Senior Director, US Medical Affairs, Field Medical Excellence, BeiGene USA, Inc.
Dr. Chad Schroer is Senior Director, Field Medical Excellence at BeiGene and is based in NYC. After building a successful family medical practice in Arizona, Chad entered industry as a Regional Medical Scientist at Boehringer Ingelheim and then moved into managing Field Medical teams... Read More →

Speakers
avatar for Stacey Gorski, PhD

Stacey Gorski, PhD

Head, US Medical Excellence, AstraZeneca
As the Head of US Medical Excellence for AstraZeneca Oncology, Stacey is currently leading a team focused on Medical omnichannel engagement, Medical education, capabilities & training, and digital transformation. As part of AstraZeneca’s efforts to prepare for the ‘Future of Medical... Read More →
avatar for Donnie Wooten Jr. Pharm.D.

Donnie Wooten Jr. Pharm.D.

Global Head Strategic Medical Content & Omnichannel, Organon
avatar for Annie Herrington, PharmD

Annie Herrington, PharmD

Vice President, Field Medical Excellence Platform Lead Medical Engagement & Impact, Pfizer
Annie began her career at Pfizer Pharmaceuticals in 2000 as a Regional Medical Research Specialist in Cardiovascular covering iconic products such as Lipitor and Norvasc as well as gaining experience in the Cardiovascular/Metabolic pipeline early engagement space.  She transitioned... Read More →

Tuesday May 7, 2024 11:00am - 11:45am EDT
Newport II
  Track: MSL Best Practices

11:45am EDT

Leveraging Foundational Analytics Platforms to Demonstrate Medical Affairs Impact
  • Understand and quantify the impact of medical affairs initiatives to optimize strategies and demonstrate value
  • Highlight the critical need to bridge methodological gaps
  • Explore how bespoke foundational analytics platforms, leveraging targeted claims data, EHR data, or medical insights, can provide a fit-for-purpose solution to measure the impact of medical actions and monitor meaningful metrics over time
Speakers
avatar for Lori Klein

Lori Klein

Partner, Medical & Scientific Affairs Practice Lead, Putnam
Lori leads the Medical and Scientific Affairs Practice at Putnam. Her expertise includes multi-stakeholder engagement, center of excellence profiling, organizational design, strategic medical launches, integrated medical evidence ideation, omnichannel strategy, and digital health... Read More →

Tuesday May 7, 2024 11:45am - 12:15pm EDT
Newport III
  Track: Medical Affairs Strategy

11:45am EDT

The Science Behind Emotions
  • Discuss the value of learning from real patient experiences to amplify the patient voice in medical affairs from diagnosis through treatment monitoring 
  • Hear from a Mental Illness Survivor and Patient Advocate share his personal journey battling treatment-resistant Major Depressive Disorder and his mission to shatter the stigma of mental illness 
  • Explore how technology supports the study of emotions and equips scientists with evidence to shape the future of clinical trial assessments 
Moderators
avatar for Priyanka Patel, PharmD

Priyanka Patel, PharmD

Managing Director, Medical, BGB Group
In her over thirteen years at BGB Group, Priyanka has been involved in developing scientific content and providing strategic direction for numerous clients, products, and projects. She has partnered with cross-functional teams to launch 10 products in countless indications across... Read More →

Speakers
avatar for Anka Gorgiev, Ph.D.

Anka Gorgiev, Ph.D.

Senior Vice President, Brand Strategy, BGB Group
Anka bring years of experience in operationalizing cognitive and behavioral science in pursuit of organizational objectives. She has helped brands across various therapeutic areas to leverage human insights and motivations to achieve business goals. Anka believes there is a wealth... Read More →
avatar for Jon Nelson

Jon Nelson

Mental Illness Survivor & Patient Advocate
Jon is a healthcare communications executive and a passionate patient advocate. He is laser focused on pulverizing the stigma of mental illness. Jon participated in a deep brain stimulation clinical trial in August 2022 out of Mt Sinai hospital in New York for treatment-resistant... Read More →

Tuesday May 7, 2024 11:45am - 12:15pm EDT
Newport I
  Track: Medical Communications

11:45am EDT

From Insights to Impact: The Power of Thought Leader Liaisons and Medical Science Liaisons in Compliant Collaboration for Meaningful Customer Engagement
  • Explore the role of a Thought Leader Liaison and how it differs from Medical Science Liaisons and sales representatives
  • Discuss way to build advocacy and what "good" looks like in compliant collaboration
  • Identify ways to best understand the needs of our HCPs and identify meaningful solutions
Speakers
avatar for Jim Hahn

Jim Hahn

Senior Business Director, Thought Leader Liaisons, EMD Serono
Jim Hahn is the Senior Business Director for the West Thought Leader Liaison team, US Neurology and Immunology. He has been with EMD Serono since 2003 in roles that include front line sales management, marketing and national commercial leadership. In his current role, Jim leads the... Read More →
avatar for Lindsay Harrer

Lindsay Harrer

Senior Business Director, East Thought Leader Liaisons U.S. Neurology & Immunology, EMD Serono
Lindsay Harrer is the Senior Business Director for the East Thought Leader Liaison team, US Neurology and Immunology. She has been with EMD Serono since 2014, in roles of increasing responsibility within the US Commercial field team. In her current role, Lindsay leads the thought... Read More →

Tuesday May 7, 2024 11:45am - 12:15pm EDT
Newport II
  Track: MSL Best Practices

12:15pm EDT

Networking Lunch
Tuesday May 7, 2024 12:15pm - 1:15pm EDT
  Networking

1:15pm EDT

Unlocking the Power of Real-World Evidence to Pave the Way for Better Patient Outcomes
Moderators
avatar for Howard Dorfman

Howard Dorfman

Founder, H.L. Dorfman Pharmaceutical Consulting, LLC
HOWARD L. DORFMAN is an Adjunct Professor and Distinguished Practitioner in Residence at Seton Hall Law School where he has taught courses on FDA Regulations, Health Law and Healthcare Compliance and is Founder of H.L. Dorfman Pharmaceutical Consulting, LLC, which provides FDA regulatory... Read More →

Speakers
avatar for Pranav Abraham, Ph.D.

Pranav Abraham, Ph.D.

Medical Evidence Strategy Leader, Global Medical Affairs, Rare Diseases, Sanofi
Pranav Abraham leads Medical Evidence Strategy for Sanofi's Global Medical Affairs Rare Diseases team. He has deep expertise in using digital health technologies to capture patient outcomes, develop novel endpoints, and leverage healthcare data for generating innovative real-world... Read More →
avatar for Christine Lemke

Christine Lemke

Co-Founder and CEO, Evidation
Christine is the Co-Founder and Chief Executive Officer of Evidation. Previously, Christine was the Co-Founder and Chief Operating Officer of Sense Networks, developers of the first machine learning platform for mobile phone activity data (exited to YP.com). She has also held roles... Read More →
avatar for Felix Lee

Felix Lee

US Digital Healthcare Medical Head, Sanofi
Felix has over 20 years in strategy and innovation building new business offerings, partnerships, investments, products and services, inside and outside healthcare, across geographies, functions and contexts.  He currently heads the medical development of digital healthcare for Sanofi... Read More →
avatar for Michael Doane, Ph.D.

Michael Doane, Ph.D.

Senior Director, Head of Health Economics and Outcomes Research (HEOR), Alkermes
Michael J. Doane is a Senior Director and Head of Health Economics and Outcomes Research (HEOR) at Alkermes, Inc. Joining Alkermes, Inc. in 2018, Michael’s expertise includes the collection, analysis, and communication of patient-centric data to quantify disease burden and identify... Read More →
avatar for Kimberly Barnholt, Ph.D

Kimberly Barnholt, Ph.D

Executive Director, Evidence Generation Leader, US Medical Affairs, Genentech
Kimberly Barnholt, Ph.D., has been a healthcare leader in various roles spanning from academic research, to disruptive start-up, to global pharmaceutical company. In all roles, she has focused on bridging science, data, and operational disciplines to challenge the status quo and transform... Read More →

Tuesday May 7, 2024 1:15pm - 2:00pm EDT
Newport III
  Track: Medical Affairs Strategy

1:15pm EDT

The Digital Renaissance of Scientific Communication: Embracing Technological Breakthroughs
  • Explore the strategies and considerations involved in effectively leveraging AI while ensuring compliance with evolving regulations 
  • Identify specific areas within medical communications where AI can be practically applied to enhance efficiency and improve the overall quality of scientific communication 
  • Delve into the ways AI can be employed to streamline the publication process, from data collection to dissemination 
  • Highlight the role of AI in providing data-driven insights that can be crucial for evaluating the effectiveness of communication strategies and making informed decisions for future initiatives

Moderators
avatar for Sonia A. Schweers, PharmD

Sonia A. Schweers, PharmD

Director, Medical Policy & Governance | Global Medical Excellence & Policy, Bristol Myers Squibb
Sonia A. Schweers is a Medical Affairs professional with over 25 years of expertise in Medical Communications, Compliance, and Publishing. Currently at Bristol-Myers Squibb (BMS), Sonia helps to advance best practices in medical activities through policy and governance, guidance... Read More →

Speakers
avatar for Sarah Guadagno, Ph.D.

Sarah Guadagno, Ph.D.

Founder and Principal, 8X Life Science Communications
Sarah Guadagno, Ph.D., has over twenty years of experience in Medical Affairs and Communications, excelling in diverse roles from leadership positions at both large and small pharmaceutical companies to her impactful work as an independent consultant. She is the founder of 8X Life... Read More →
avatar for Daina Nanchanatt, PharmD

Daina Nanchanatt, PharmD

Director, Oncology Scientific Communications, Bayer
Daina Nanchanatt, PharmD, RPh, serves as Director of Scientific Communications within the Oncology Global Medical Affairs group at Bayer. Daina is the SciComm lead for a key product within Bayer’s Prostate Cancer Portfolio, and oversees a team responsible for creating and translating... Read More →
avatar for Christine Wyble

Christine Wyble

Head Scientific Communication & Field Medical, Novartis

Tuesday May 7, 2024 1:15pm - 2:00pm EDT
Newport I
  Track: Medical Communications

1:15pm EDT

Business is Not a Dirty Word for MSL’s
Moderators
avatar for Conner Blaine Hampton PharmD, RPh.

Conner Blaine Hampton PharmD, RPh.

Director, National Accounts, Pharmacosmos Therapeutics Inc.
Conner Blaine Hampton (He/Him/His) is a class of 2018 University of Kansas School of Pharmacy alumnus. Followinggraduation in 2018, he pursued a post-doctoral pharmaceutical industry fellowship in Medical Affairs andPharmaceutical Marketing with American Regent, Inc. and Daiichi Sankyo... Read More →

Speakers
avatar for Varun Nagpal, Ph.D.

Varun Nagpal, Ph.D.

US Regional Director Medical Affairs - Global Thoracic Oncology - Global Medical & Scientific Affairs, Merck
Varun Nagpal is an accomplished leader in medical strategy, specifically in the fields of thoracic oncology and solid tumors. He is currently working as the Regional Medical Director, Global Medical Affairs at Merck. Prior to this role, he has held various positions leading medical... Read More →
avatar for Edmund H. Doherty

Edmund H. Doherty

Senior Consultant and Founder, Blue Jay Medical Affairs Consulting, LLC.
Edmund Doherty is currently overseeing Blue Jay Medical Affairs Consulting and working on various projects. Edmund holds a Doctor of Pharmacy from Creighton University and has over 20 years of Medical Affairs experience with various positions of increasing responsibility including... Read More →
avatar for Megan Grosso

Megan Grosso

Head of US Medical Affairs, Amylyx Pharmaceuticals
As Head of US Medical Affairs, Megan is responsible for driving medical strategy, clinical insights, scientific communications, and data generation efforts that improve the lives of those living with neurodegenerative diseases. Megan joined Amylyx Pharmaceuticals, Inc. in summer... Read More →
avatar for Lori Lebson, Ph.D.

Lori Lebson, Ph.D.

Senior Vice President North America Medical Affairs, EMD Serono
As Senior Vice President, North America Medical Affairs, Lori leads the Neurology and Immunology, Oncology, Fertility and HIV teams responsible for driving medical strategy, clinical insights, scientific communications, and data generation to transform patient care. Lori joined... Read More →

Tuesday May 7, 2024 1:15pm - 2:00pm EDT
Newport II
  Track: MSL Best Practices

2:00pm EDT

The Pivotal Role in Ensuring Access to Innovative Products: New Normal for Medical Affairs
  • Discuss the critical need for Medical Affairs professionals to build specific competencies in navigating the complex landscape of Rare Disease policy shaping
  • Explore the significance of developing a tailored (RWE) strategy early in the launch planning process and the impact of early stakeholder conversations in shaping the RWE strategy  
  • Highlight the pivotal role of Medical Affairs leadership in elevating the voice of patients and embrace patient reported outcome measures (PROMs) to enhance access outcomes 
  • Delve into the importance of funneling field insights to develop optimal objection handlers and establish the right value-based agreement strategy 
Speakers
avatar for Siddharth Jain, MD.

Siddharth Jain, MD.

Medical Director (Global Medical Lead, HAE & LSDs), Takeda
Siddharth is an accomplished Medical Affairs leader (15+ years) with a diverse, multicultural experience in reputed organizations with successful stints in varied therapies (including Rare diseases). His strengths are collaborating with stakeholders from varied cultural & ethnic diversities... Read More →

Tuesday May 7, 2024 2:00pm - 2:30pm EDT
  Track: Medical Affairs Strategy

2:00pm EDT

Transformative Applications of Generative AI Analytics: Optimizing Next Best Actions and Assessing Medical Team Impact
  • Explore strategies for integrating data analytics into stakeholder engagement plans to harness data-driven insights and drive medical affairs strategy 
  • Utilize sentiment analysis to measure the impact of medical affairs and enhance KOL engagement 
  • Illustrate how generative AI and analytics can produce "next best actions" and "next best experts" customized to your specific unique goals and situations 
 
Speakers
avatar for Stephanie Otis

Stephanie Otis

Vice President of US Medical Affairs, Ferring Pharmaceuticals
Stephanie Otis is the Vice President of US Medical Affairs at Ferring Pharmaceuticals.  In her role, she is responsible for driving strategies that contribute to medical excellence and scientific leadership, bringing life changing therapies to help people build families and live... Read More →
avatar for Badal Shah, B.Pharm, M.S., M.B.A.

Badal Shah, B.Pharm, M.S., M.B.A.

Founder & President, Neolytica – A QPharma Company
Badal Shah, Managing Director of QPharma Inc., is a visionary leader whose strategic innovations in the pharmaceutical industry have marked him as a trailblazer. Arriving in the US at 22, his ambition led him to not only ascend to a pivotal role within QPharma but also to found Neolytica... Read More →

Tuesday May 7, 2024 2:00pm - 2:30pm EDT
Newport I
  Track: Medical Communications

2:00pm EDT

Mastering Collaboration: Strategies for Championing Thought Leader Engagement
  • Highlight the pivotal position of thought leader engagement in shaping medical insights, research, and practice
  • Explore dynamic methods and tools to identify emerging voices and perspectives in the medical community
  • Discuss strategies for fostering effective communication, aligning objectives, and optimizing resources across field teams
Speakers
avatar for Carol Bowes Lawlor, DO.

Carol Bowes Lawlor, DO.

Senior National Director, Field Medical, Alkermes
Carol Bowes Lawlor, DO is the Senior National Director for Field Medical, Northeast at Alkermes. She previously held the position of a Senior MSL at Alkermes and Director, Regional Diabetes Faculty, Market Development and HCP Engagement at Novo Nordisk. Prior to entering the biopharmaceutical... Read More →
avatar for Marybeth Garnitz

Marybeth Garnitz

Senior Director Medical Relations, Alkermes

Tuesday May 7, 2024 2:00pm - 2:30pm EDT
Newport II
  Track: MSL Best Practices

2:30pm EDT

Networking Break
Tuesday May 7, 2024 2:30pm - 3:00pm EDT
  Networking

3:00pm EDT

Operating with Impact: Topical Transformation Dilemmas and Decisions
  • Discuss the importance of operating with an impact
  • Identify the hallmarks of impactful operations for Medical Affairs
  • Explore the different strategies for operational transformation?
Speakers
avatar for Gemma Pfister

Gemma Pfister

Senior Executive, Vynamic

Tuesday May 7, 2024 3:00pm - 3:30pm EDT
Newport III
  Track: Medical Affairs Strategy

3:00pm EDT

Agile Scientific Communications in Medical Affairs: From Pandemic Pressure to Generative AI
  • Understand real-time communication demands and the importance for MSLs to navigate the flood of information in real-time to stay abreast of new findings and developments to ensure timely and accurate communication with stakeholders
  • Discover how strategic enablement of agile messaging and content creation enhances responsiveness in medical communication and strategies to adapt messaging rapidly to evolving circumstances, ensuring relevance and credibility in dynamic environments
  • Explore innovative strategies for launching a digital scientific communication platform and developing custom GPTs and discuss how these technologies ease the burden of content creation, enabling MSLs to focus on high-value activities and enhance efficiency
Speakers
avatar for Rachel Kennedy, Ph.D.

Rachel Kennedy, Ph.D.

Senior Director, Head of Scientific Communications, Moderna
Rachel is a trained Neuroimmunologist (Post-Doc Columbia University, PhD GSBSE Maine) who joined industry as an MSL supporting Multiple Sclerosis in NYC and later Boston. She has been in various global medical roles over the past 5 years, including Chief of Staff to the CMO, Strategy... Read More →
avatar for Mary Bausch-Jurken, Ph.D.

Mary Bausch-Jurken, Ph.D.

Global Scientific Communications Lead COVID-19, Moderna
Mary has a PhD in Cellular biology and a Masters degree in clinical and translational science (Medical College of Wisconsin.) After years in academia working in clinical immunology, Mary entered industry as an MSL. After working in pulmonary, cardiovascular and rare disease, she came... Read More →

Tuesday May 7, 2024 3:00pm - 3:30pm EDT
Newport I
  Track: Medical Communications

3:00pm EDT

Building Medical Capabilities by Design
  • Discuss concepts central to designing learning activities to produce desired business outcomes 
  • Understand learning design analysis and requirements needed to move a learner from “knowing” to “doing” to affect a business's bottom-line measures 
  • Identify commonly used models that aid in effective learning design 
  • Learn how to apply concepts from a real-life example in future training projects to build capabilities and increase business outcomes
Speakers
avatar for Mary Winkels, PharmD

Mary Winkels, PharmD

Global Director, Medical Affairs Training and Capability, Vertex Pharmaceuticals

Tuesday May 7, 2024 3:00pm - 3:30pm EDT
Newport II
  Track: MSL Best Practices

3:30pm EDT

Patient-Centric Initiatives: Empowering Patients and Rebuilding Trust in Medical Affairs
  • Recognize the value of patient-centric initiatives in enhancing trust with external stakeholders, emphasizing the importance of aligning organizational efforts with patient needs and preferences  
  • Understand the role of medical affairs in empowering patients to take an active role in their healthcare, promoting informed decision-making and enhancing patient engagement for better health outcomes
  • Learn methods for measuring the impact of patient-centric initiatives on organizational outcomes, emphasizing the value of incorporating patient perspectives into key metrics for demonstrating the effectiveness of medical affairs efforts
Moderators
avatar for Rohita Sharma, Ph.D.

Rohita Sharma, Ph.D.

Global Sr. Director - Patient Insights and Solutions - Medical Affairs, Alexion Pharmaceuticals
Rohita Sharma, PhD, is a Global Sr. Director in the Patient Insights & Solutions – Medical Affairs team at Alexion AstraZeneca Rare Disease.Rohita has more than 15 years’ experience in the pharmaceutical industry mainly in medical affairs. She has worked across commercial, medical... Read More →

Speakers
avatar for Tiffany Patrick

Tiffany Patrick

Former Vice President, Patient Advocacy and Engagement, Alnylam Pharmaceuticals, Inc.
Tiffany Patrick, MPH, MBA, is a seasoned Medical Affairs leader. Most recently, as Vice President of Patient Advocacy and Engagement at Alnylam Pharmaceuticals, Inc., she led the development and execution of patient engagement strategies for Alnylam’s rare and ultra-rare disease... Read More →
avatar for Gustavo Suarez Zambrano, M.D.

Gustavo Suarez Zambrano, M.D.

Vice President and Head of Medical Affairs, Mitsubishi Tanabe Pharma America
As our Vice President of Medical Affairs, Gustavo A. Suarez Zambrano, M.D. is the most senior medical authority for the company and oversees all Medical Affairs activities in North America. He has almost 20 years of combined experience in clinical neurology and pharmaceutical medical... Read More →
avatar for Colleen Chapman

Colleen Chapman

Senior Director, Patient Advocacy Lead, Relay Therapeutics

Tuesday May 7, 2024 3:30pm - 4:15pm EDT
Newport III
  Track: Medical Affairs Strategy

3:30pm EDT

The Many Languages of Med Affairs: How Communicating Well with Diverse Audiences Drives Success
  • Discuss the importance of recognizing the unique language and motivations of different stakeholders in the healthcare ecosystem, such as healthcare professionals (HCPs), pharmacists, purchasing organizations, commercial colleagues, and senior business leadership 
  • Explore how tailored communication strategies can lead to positive outcomes, whether it be increased collaboration, improved partnerships, or better patient outcomes 
  • Highlight key performance indicators and metrics for assessing the effectiveness of communication strategies in medical affairs

Moderators
avatar for Patricia Novy

Patricia Novy

Vice President of Medical Affairs, Dynavax
Dr. Novy joined Dynavax in 2021 and currently serves as Vice President, Medical Affairs. She comes to the company with more than 10 years of experience in the vaccines field. Dr. Novy joined Dynavax from Moderna, where she was Senior Director, Global Medical Affairs, responsible for... Read More →

Speakers
avatar for Aaron Hazzard, MS, CMPP

Aaron Hazzard, MS, CMPP

Director of Publication Management,, Merck & Co., Inc.
Aaron is a Director of Publication Management at Merck & Co., Inc, where he has led strategic publication plans primarily in oncology for over 10 years. Previously, he worked for more than 10 years implementing publication plans at a medical communications agency. Aaron earned a Master’s... Read More →
avatar for Rebecca McCracken

Rebecca McCracken

Global Scientific Communications & Publications, Agios Pharmaceuticals
Rebecca McCracken is Head of Global Scientific Communications & Publications within the Global Medical Affairs group at Agios. Rebecca leads a team of experts that drive the development and execution of strategic scientific communication plans across the Agios pipeline. Rebecca has... Read More →
avatar for Pallavi Jain, PharmD

Pallavi Jain, PharmD

Director, Payer & HEOR Medical Science Liaison, Argenx
Pallavi is currently a payer & HEOR MSL at Argenx and has 7+ years within small and large companies across many rare diseases. Pallavi earned her PharmD from Massachusetts College of Pharmacy in Boston. After completion of  pharmacy school, Pallavi pursued a PharmD Fellowship in... Read More →
avatar for Amy Calamari

Amy Calamari

Director, Scientific Communications, Gilead
Amy Calamari is an Oncology Publication Director in the Scientific Communication group at Gilead Sciences and has over 25 years of experience in the pharmaceutical industry. Before joining Gilead, she was a Publication Director within the Global Scientific and Medical Publications... Read More →

Tuesday May 7, 2024 3:30pm - 4:15pm EDT
Newport I
  Track: Medical Communications

3:30pm EDT

Pioneers in Medical Affairs: Beyond Traditional MSL Roles
  • Discuss the changing role of MSL's in response to advancements in medical technology and shifts in healthcare delivery models, exploring how these changes are reshaping traditional MSL responsibilities and expectations 
  • Envision the future of medical affairs beyond conventional practices, considering emerging trends and technologies that are likely to influence the field, and identifying key areas where MSLs can contribute to driving innovation and success
  •  Identify essential skills and competencies that will be crucial for MSLs to excel in the evolving landscape of medical affairs, such as adaptability to new technologies, strong communication abilities, strategic thinking, and the ability to navigate complex healthcare environments  
Moderators
avatar for Sagar Shah

Sagar Shah

Global Lead, Oncology Field Medical Excellence, Pfizer
Sagar’s 20 year path within the industry has been a fulfilling and impactful journey. Being blessed with mentors and great leaders along the way, Sagar consistently sought out the uncomfortable. He received his PharmD from Rutgers University School of Pharmacy and was subsequently... Read More →

Speakers
avatar for Scott McConnell

Scott McConnell

Medical Affairs Clinical Consultant, Xilio Therapeutics
avatar for Joanna Gonsalves

Joanna Gonsalves

Executive Director, Global Field Medical Excellence, Amgen
Joanna Gonsalves has 16+years of experience in the bio-pharmaceutical industry. Joanna joined Amgen in April 2010 as a Nephrology Medical Science Liaison (MSL).  During her tenure at Amgen Joanna has held a variety of different roles in different therapeutic areas.  As the US lead... Read More →
avatar for Sunil Mehta

Sunil Mehta

Vice President, Head of US Medical Affairs, Argenx
Sunil completed his PharmD from Rutgers University followed by a Medical Affairs and Medical Strategy post-doctoral fellowship at BMS in Cardiology & Infectious Diseases (ID) where he was involved in helping develop Medical strategy & Training for Medical Affairs and Commercial organizations... Read More →

Tuesday May 7, 2024 3:30pm - 4:15pm EDT
Newport II
  Track: MSL Best Practices

4:15pm EDT

Track Chairperson’s Closing Remarks
Speakers
avatar for Kanchan Relwani

Kanchan Relwani

Senior Vice President, Head of Medical Affairs, Alkermes
Kanchan Relwani, M.D. serves as Alkermes’ Senior Vice President of Medical Affairs. In this role, Dr. Relwani leads the Medical Affairs organization, including oversight of the Medical Strategy, Medical Operations & Alliances, Heath Economics and Outcomes Research, Medical Information... Read More →

Tuesday May 7, 2024 4:15pm - 4:30pm EDT
  Track: Medical Affairs Strategy

4:15pm EDT

Track Chairperson's Closing Remarks
Speakers
avatar for Melanie Fleeman, Ph.D.

Melanie Fleeman, Ph.D.

Executive Director, Head of Scientific Communications, Education & Digital Content, Bayer
Melanie Fleeman, PhD, serves as Executive Director and Head of Scientific Communications, Education & Digital Content, within the Oncology Global Medical Affairs group at Bayer. Melanie oversees a team of talented scientific experts in their mission to transform data into innovative... Read More →

Tuesday May 7, 2024 4:15pm - 4:30pm EDT
  Track: Medical Communications

4:15pm EDT

Track Chairperson's Closing Remarks
Speakers
avatar for Jill Fenwick, Ph.D.

Jill Fenwick, Ph.D.

Global Head of Medical Learning, EMD Serono
Jill has a PhD in Lung Cancer plus 25 years in pharmaceutical industry in UK, initially in commercial, but then over 15 years in Medical Affairs. Predominantly in psychiatry and oncology therapy areas. As field-based Medical Affairs worked as an MSL, European MSL (responsible for... Read More →

Tuesday May 7, 2024 4:15pm - 4:30pm EDT
  Track: MSL Best Practices

4:30pm EDT

Conference Concludes
Tuesday May 7, 2024 4:30pm - 4:30pm EDT
  Networking
 
Wednesday, May 8
 

8:00am EDT

Workshop Day: Registration and Networking Breakfast
Wednesday May 8, 2024 8:00am - 9:00am EDT
  Networking

9:00am EDT

Morning Workshop A - Thrive, not just survive, through change
Change is inevitable – join us for a session where we will: 
  • Describe the types of change that we may face and how each can affect us 
  • Explain the psychology of change and the transition model 
  • Apply tools and techniques for thriving through change 
  • Build personal resilience 
  • Increase personal adaptability 
Speakers
avatar for Jill Fenwick, Ph.D.

Jill Fenwick, Ph.D.

Global Head of Medical Learning, EMD Serono
Jill has a PhD in Lung Cancer plus 25 years in pharmaceutical industry in UK, initially in commercial, but then over 15 years in Medical Affairs. Predominantly in psychiatry and oncology therapy areas. As field-based Medical Affairs worked as an MSL, European MSL (responsible for... Read More →
avatar for Shannon Colton

Shannon Colton

Founder and Consultant, MarbleWing Consulting
Shannon Colton is a PhD biologist by training and a passionate trainer by experience. Shannon has spent her professional career growing within the space of science education and communication. From teaching courses at a university to modeling proteins with 3D printers, Shannon has... Read More →
avatar for Ian Casci

Ian Casci

Director, Medical Excellence and Training, Pharmacosmos Therapeutics Inc.
Ian Casci earned his PhD in Human Genetics at the University of Pittsburgh where he studied genetic modifiers of Amyotrophic Lateral Sclerosis (ALS) in fruit fly models. After receiving his doctorate, he joined EMD Serono as a Medical Science Liaison in neurology and immunology.Next... Read More →

Wednesday May 8, 2024 9:00am - 10:30am EDT
Newport I
  Workshop: Morning

9:00am EDT

Morning Workshop B- Cracking the Code: Strategies for Communicating the Impact of Medical Affairs
  • Gain clarity on how to effectively define and measure the impact of Medical Affairs activities using an impact model and directed insights framework.
  • Understand the importance of translating your medical plan into an actionable scientific narrative that highlights the value of Medical Affairs efforts.
  • Practice professional tips for utilizing digital tools and data visualization techniques to communicate the impact of Medical Affairs in a clear insights-to-action report.
Speakers
avatar for Renu Juneja, Ph.D.

Renu Juneja, Ph.D.

Head, Scientific Evidence & Communications, Oncology US Medical Affairs, Johnson & Johnson
avatar for Linda Traylor, Ph.D.

Linda Traylor, Ph.D.

Vice President, Head of Medical Excellence, Acceleration Point
Dr. Traylor is a highly respected leader in medical affairs, with 25 years of experience. She earned her Ph.D. from the University of Arkansas and completed her post-doctoral fellowship at Duke University. Throughout her career, she has held positions as a Medical Science Liaison... Read More →

Wednesday May 8, 2024 9:00am - 10:30am EDT
Newport II
  Workshop: Morning

10:30am EDT

Networking Break
Wednesday May 8, 2024 10:30am - 11:00am EDT
  Networking

11:00am EDT

Afternoon Workshop C - Medical Science Liaison Compliance Essentials : A Workshop for Success in the US
Participants will: 
  • Identify common compliance challenges MSLs face and identify potential areas of focus for own organization
  • Describe potential partners within organizations to address MSL compliance risks and gaps
  • Select from among provided best practices to make plans to address potential gaps/improve MSL compliance programs
  • Recognize power skills to develop among MSLs that can help them successfully navigate compliance challenges

Speakers
avatar for Mary Winkels, PharmD

Mary Winkels, PharmD

Global Director, Medical Affairs Training and Capability, Vertex Pharmaceuticals
avatar for Adeola Davis

Adeola Davis

Director of Learning and Development, Medical Affairs, Acadia Pharmaceutical

Wednesday May 8, 2024 11:00am - 12:30pm EDT
Newport I
  Workshop: Early Afternoon

11:00am EDT

Afternoon Workshop D - “Once upon a time in medical affairs…”: How storytelling fits into communicating data – the numbers don’t speak for themselves
In this session, we will: 
  • Debuzz the term “storytelling” to make it practical and applicable to communicating the scientific narrative 
  • Demonstrate how to use storytelling to make data memorable 
  • Practice weaving together a medical/scientific story that appeals to logic and/or emotion 
  • Provide takeaway training frameworks to help your teams enhance their ability to craft their narratives 
Speakers
avatar for Jill Fenwick, Ph.D.

Jill Fenwick, Ph.D.

Global Head of Medical Learning, EMD Serono
Jill has a PhD in Lung Cancer plus 25 years in pharmaceutical industry in UK, initially in commercial, but then over 15 years in Medical Affairs. Predominantly in psychiatry and oncology therapy areas. As field-based Medical Affairs worked as an MSL, European MSL (responsible for... Read More →
avatar for Shannon Colton

Shannon Colton

Founder and Consultant, MarbleWing Consulting
Shannon Colton is a PhD biologist by training and a passionate trainer by experience. Shannon has spent her professional career growing within the space of science education and communication. From teaching courses at a university to modeling proteins with 3D printers, Shannon has... Read More →
avatar for Ian Casci

Ian Casci

Director, Medical Excellence and Training, Pharmacosmos Therapeutics Inc.
Ian Casci earned his PhD in Human Genetics at the University of Pittsburgh where he studied genetic modifiers of Amyotrophic Lateral Sclerosis (ALS) in fruit fly models. After receiving his doctorate, he joined EMD Serono as a Medical Science Liaison in neurology and immunology.Next... Read More →

Wednesday May 8, 2024 11:00am - 12:30pm EDT
Newport II
  Workshop: Early Afternoon

12:30pm EDT

Networking Lunch
Wednesday May 8, 2024 12:30pm - 1:30pm EDT
  Networking
 
Filter sessions
Apply filters to sessions.
Monday, May 6
Tuesday, May 7
Wednesday, May 8
Newport I
Newport II
Newport III
The Westin, Jersey City
  • General Session
  • Networking
  • Track: Medical Affairs Strategy
  • Track: Medical Communications
  • Track: MSL Best Practices
  • Workshop: Early Afternoon
  • Workshop: Morning